Organisation
HIV/STI Clinic
Current researchers
1 - 10 of 20 results
- Maureen Aerts (Member)
- Ludwig Apers (Member)
- Vincent Barvaux (Member)
- Séverine Caluwaerts (Member)
- Emmanuelle Cleve (Member)
- Eva Hemelaer (Member)
- Corinne Herrijgers (Member)
- Veerle Huyst (Member)
- Ilse Kint (Member)
- Cora Lamonte (Member)
Projects
1 - 9 of 9
- Contemporary challenges in Human Immunodeficiency Virus Pre-Exposure-Prophylaxis care in BelgiumFrom15 Nov 2022 → Today
- PReventing the Emergence of untreatable STIs via radical PreventionFrom1 Jan 2021 → Today
- Ontwikkeling en evaluatie van een gecomputeriseerde interventie voor chemsex ondersteuningFrom19 Nov 2020 → 31 Dec 2021
- Chemified: pilot testing of a mobile application for chemsexcare and supportFrom20 Oct 2020 → 20 Oct 2021
- Optimise PrEP to Maximise ImpactFrom1 Jan 2019 → 31 Dec 2023
- Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised careFrom1 May 2015 → 30 Sep 2020
- Analytical treatment interruption in HIV positive patients with low viral reservoir to evaluate the potential of a functional cureFrom1 Nov 2014 → 31 Oct 2018
- Hepatitis C treatment for HIV patients in resource-poor countries: is a public health approach possibleFrom1 Jul 2014 → 31 Dec 2019
- Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in EuropeFrom1 Apr 2014 → 30 Sep 2017
Publications
21 - 30 of 295
- Mixed arterial and venous thromboembolism in a person with HIV infection(2003)
Authors: Steven Callens, E Florence, M Philippe, M Van der Planken, R Colebunders
Pages: 907-908 - Prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment [review editorial](2005)
Authors: L Apers, L Lynen, W Worodria, R Colebunders
Pages: 1209-1214 - Safe and effective use of combination antiretroviral treatment(1999)
Authors: R Colebunders, N Clumeck, E Florence, B. Vandercam, F Van Wanzeele, E Van Wijngaerden, P. Lacor, J Demonty, S. De Wit
Pages: 55-60 - Immediate vs. deferred switching from a boosted protease inhibitor (PI/r) based regimen to a dolutegravir (DTG) based regimen in virologically suppressed patients with high cardiovascular risk or age ≥50 years: final 96 weeks results of NEAT 022 study(2018)
Authors: Jose M. Gatell, Lambert Assoumou, Graeme Moyle, Laura Waters, Margaret Johnson, Pere Domingo, Julie Fox, Esteban Martinez, Hans-Jürgen Stellbrink, Giovanni Guaraldi, et al.
Pages: 597-606 - 48-week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study(2018)
Authors: E Martinez, Lambert Assoumou, G Moyle, Laura Waters, M. Johnson, Pere Domingo, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Mar Masia, et al.
- Perceptions of ageing and desire for ageing information amongst users of the EmERGE mHealth platform(2019)
Authors: T. Levett, Jaime Vera, C. Jones, S. Bremner, D Aguilar Leon, J Begovac, L. Apers, M. Borges, S. Zekan, E. Teofilo, et al.
Pages: 137-137 - 8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: a single-arm multicenter phase 3b study (HepNed-001)(2018)
Authors: Anne Boerekamps, T. Vanwolleghem, Marc van der Valk, E. Van den Berk Guido, D. Posthouwe, D. Anton, B. V. Hoek, S. Ramsoekh, Marjo E van Kasteren, Janke Schinkel, et al.
Pages: S122-S123 - Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium(2023)
Authors: R. Nasreddine, Eric Florence, JC Yombi, Sophie Henrard, Gilles Darcis, J. T. Van Praet, L Vandekerckhove, Sabine D. Allard, R Demeester, P. Messiaen, et al.
Pages: 914-924 - Lessons learnt from the experiences of primary care physicians facing COVID-19 in Benin: a mixed-methods study(2022)
Authors: Kéfilath Bello, Jan De Lepeleire, Mahugnon C. U. Agossou, L Apers, DM Zannou, B Criel
- A truncated HIV Tat demonstrates potent and specific latency reversal activity(2023)
Authors: Ellen Van Gulck, Marion Pardons, Erik Nijs, Nick Verheyen, Koen Dockx, C Van den Eynde, Emilie Battivelli, J Vega, Eric Florence, Brigitte Autran, et al.